Thomas T. Kubic
Thomas T. Kubic is the President and CEO of the Pharmaceutical Security Institute (PSI), a non-profit association dedicated to protecting the public health by insuring the distribution of pharmaceuticals that are safe and effective. Mr. Kubic currently serves on the World Health Organization’s IMPACT Enforcement Working Group, the Interpol Intellectual Property Crime Action Group, and in an advisory capacity to the Permanent Forum Against International Pharmaceutical Counterfeiting. He is the Treasurer for the Partnership for Safe Medicines. Additionally, he has provided testimony before senior government officials around the world concerning the international nature of counterfeiting and its devastating impact.
Composed of the security directors from 26 pharmaceutical manufacturers with business operations in more than 160 countries, PSI shares information on the counterfeiting of pharmaceuticals and initiates enforcement actions through the appropriate authorities. Under Mr. Kubic’s leadership, PSI was completely reorganized to emphasize information sharing and private-public sector cooperation. Major advances included the development of the PSI Anti-Counterfeiting Strategy and a unique, internationally recognized counterfeit medicines reporting system, the Counterfeit Incident System.
Prior to joining PSI, Mr. Kubic acquired substantial national and international investigative experience during his 30-year career a federal law enforcement executive for the U.S. Federal Bureau of Investigation (FBI). As a FBI Deputy Assistant Director, his innovative programs in both the Laboratory Division and Criminal Investigative Division were recognized throughout the law enforcement community.
Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!
